OR WAIT null SECS
June 22, 2020
The company will invest $75 million into its Canton, MA, facility to expand its viral vector, gene therapy, and contract development and manufacturing capabilities.
June 08, 2020
Previous investments set a foundation for later efficiency improvements.
June 04, 2020
The VIA Capsule from Cytiva is a liquid nitrogen-free cryogenic shipment system designed to transport cell therapies.
May 18, 2020
Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing.
May 15, 2020
Synthetic depth filters are a suitable option to provide a high-performance and scalable single-step clarification process.
May 13, 2020
The company will invest $180 million to construct a new 290,000-ft2 facility in Plainville, MA.
Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma entered into long-term development and manufacturing services agreements for the clinical and commercial supply of multiple bluebird bio therapies.
May 06, 2020
The center will be located at NJIT’s Life Sciences and Engineering center and will feature two good manufacturing practices suites that are expected to be completed and operational during the summer of 2020.
May 01, 2020
The new cell-line producing platform enables fully scalable production of high-performance adeno-associated virus vectors.
April 21, 2020
The company will build an additional commercial-scale, contract manufacturing facility for viral vectors and gene therapies near its existing site in Carlsbad, CA.